New determinants of prognosis in bacterial infections in cirrhosis
- PMID: 24966596
- PMCID: PMC4064071
- DOI: 10.3748/wjg.v20.i23.7252
New determinants of prognosis in bacterial infections in cirrhosis
Abstract
Despite major advances in the knowledge and management of liver diseases achieved in recent decades, decompensation of cirrhosis still carries a high burden of morbidity and mortality. Bacterial infections are one of the main causes of decompensation. It is very important for clinical management to be aware of the population with the highest risk of poor outcome. This review deals with the new determinants of prognosis in patients with cirrhosis and bacterial infections reported recently. Emergence of multiresistant bacteria has led to an increasing failure rate of the standard empirical antibiotic therapy recommended by international guidelines. Moreover, it has been recently reported that endothelial dysfunction is associated with the degree of liver dysfunction and, in infected patients, with the degree of sepsis. It has also been reported that relative adrenal insufficiency is frequent in the non-critically ill cirrhotic population and it is associated with a higher risk of developing infection, severe sepsis, hepatorenal syndrome and death. We advise a change in the standard empirical antibiotic therapy in patients with high risk for multiresistant infections and also to take into account endothelial and adrenal dysfunction in prognostic models in hospitalized patients with decompensated cirrhosis.
Keywords: Bacterial; Bacterial infections; Drug resistance; Endothelial dysfunction; Liver cirrhosis; Relative adrenal insufficiency.
Figures





Similar articles
-
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2. J Hepatol. 2019. PMID: 30391380
-
Risk factors and outcome of bacterial infections in cirrhosis.World J Gastroenterol. 2014 Mar 14;20(10):2542-54. doi: 10.3748/wjg.v20.i10.2542. World J Gastroenterol. 2014. PMID: 24627590 Free PMC article. Review.
-
Management of bacterial infections in cirrhosis.J Hepatol. 2012;56 Suppl 1:S1-12. doi: 10.1016/S0168-8278(12)60002-6. J Hepatol. 2012. PMID: 22300459 Review.
-
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.PLoS One. 2015 May 21;10(5):e0127448. doi: 10.1371/journal.pone.0127448. eCollection 2015. PLoS One. 2015. PMID: 25996499 Free PMC article.
-
Sepsis in Patients With Cirrhosis Awaiting Liver Transplantation: New Trends and Management.Liver Transpl. 2019 Nov;25(11):1700-1709. doi: 10.1002/lt.25621. Epub 2019 Sep 18. Liver Transpl. 2019. PMID: 31408581 Review.
Cited by
-
Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions.World J Gastrointest Endosc. 2015 May 16;7(5):524-31. doi: 10.4253/wjge.v7.i5.524. World J Gastrointest Endosc. 2015. PMID: 25992191 Free PMC article. Review.
-
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial.BMJ Open. 2018 Oct 21;8(10):e023754. doi: 10.1136/bmjopen-2018-023754. BMJ Open. 2018. PMID: 30344180 Free PMC article.
-
Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt.Infect Drug Resist. 2019 Jul 24;12:2277-2282. doi: 10.2147/IDR.S208954. eCollection 2019. Infect Drug Resist. 2019. PMID: 31413604 Free PMC article.
-
An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver Disease.J Clin Exp Hepatol. 2017 Dec;7(4):305-309. doi: 10.1016/j.jceh.2017.05.003. Epub 2017 May 15. J Clin Exp Hepatol. 2017. PMID: 29234194 Free PMC article.
-
PREVALENCE AND FACTORS ASSOCIATED WITH BACTERIAL INFECTION IN CIRRHOTIC PATIENTS IN TOGO.Arq Gastroenterol. 2025 Jul 21;62:e24037. doi: 10.1590/S0004-2803.24612024-37. eCollection 2025. Arq Gastroenterol. 2025. PMID: 40699040 Free PMC article.
References
-
- Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593–608. - PubMed
-
- Zatoński WA, Sulkowska U, Mańczuk M, Rehm J, Boffetta P, Lowenfels AB, La Vecchia C. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res. 2010;16:193–201. - PubMed
-
- Fernández J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012;56 Suppl 1:S1–12. - PubMed
-
- Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–148. - PubMed
-
- Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55:1551–1561. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical